PE20011266A1 - Derivados de 1,4-diazepan-2,5-diona - Google Patents
Derivados de 1,4-diazepan-2,5-dionaInfo
- Publication number
- PE20011266A1 PE20011266A1 PE2001000458A PE2001000458A PE20011266A1 PE 20011266 A1 PE20011266 A1 PE 20011266A1 PE 2001000458 A PE2001000458 A PE 2001000458A PE 2001000458 A PE2001000458 A PE 2001000458A PE 20011266 A1 PE20011266 A1 PE 20011266A1
- Authority
- PE
- Peru
- Prior art keywords
- diona
- diazepan
- derivatives
- heteroaryl
- benzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
SE REFIERE A DERIVADOS DE 1,4-DIAZEPAN-2,5-DIONA DONDE R1 Y R2 SON ARILO, HETEROARILO CON HALOGENO, CF3, ALCOXILO, ALQUILO; R3 ES H, ALQUILO , -(CH2)nN(R)2, -(CH2)n-HETEROARILO, -(CH2)n-HETEROCICLO, ENTRE OTROS; R4 ES =O, =N(CH2)nCH3, =N(CH2)nN(R2); R3 Y R4 JUNTO A N, C FORMAN EL GRUPO -CR5=N-N=; R5 ES H, -(CH2)nN(R)2, -(CH2)n-HETEROARILO, (CH2)n-HETEROCICLO, ENTRE OTROS; R ES H, ALQUILO; n ES 0-3. SON COMPUESTOS PREFERIDOS (3S)-1-(3,5-BIS-TRIFLUOROMETIL-BENCIL)-3-(3,4-DICLOROBENCIL)-[1,4]DIAZEPAN-2,5-DIONA, (3S)-3-(3,4-DICLORO-BENCIL)-1-(2-METOXI-NAFTALEN-1-IL-METIL)-[1,4]DIAZEPAN-2,5-DIONA, (3S)-3-(3,4-DICLORO-BENCIL)-1-(2-METIL-NAFTALEN-1-IL-METIL)-[1,4]DIAZEPAN-2,5-DIONA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y COMPUESTOS INTERMEDIOS. LOS DERIVADOS DE 1,4-DIAZEPAN-2,5-DIONA SON ANTAGONISTAS DEL RECEPTOR DE LA NEUROQUININA 1 (NK-1) Y SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL, ENFERMEDADES INFLAMATORIAS TAL COMO MIGRANA, ARTRITIS REUMATOIDE, ASMA, PARKINSON
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00111249 | 2000-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20011266A1 true PE20011266A1 (es) | 2001-12-14 |
Family
ID=8168838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000458A PE20011266A1 (es) | 2000-05-25 | 2001-05-21 | Derivados de 1,4-diazepan-2,5-diona |
Country Status (18)
Country | Link |
---|---|
US (1) | US6452001B2 (es) |
EP (1) | EP1296961B1 (es) |
JP (1) | JP4060596B2 (es) |
KR (1) | KR100526696B1 (es) |
CN (1) | CN1178923C (es) |
AR (1) | AR028607A1 (es) |
AT (1) | ATE353881T1 (es) |
AU (2) | AU8177801A (es) |
BR (1) | BR0111062A (es) |
CA (1) | CA2409842C (es) |
DE (1) | DE60126614T2 (es) |
DK (1) | DK1296961T3 (es) |
ES (1) | ES2280392T3 (es) |
MX (1) | MXPA02011464A (es) |
PE (1) | PE20011266A1 (es) |
PT (1) | PT1296961E (es) |
WO (1) | WO2001090083A1 (es) |
ZA (1) | ZA200208940B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA90708C2 (ru) | 2005-02-25 | 2010-05-25 | Ф. Хоффманн-Ля Рош Аг | Таблетки с улучшенной дисперсностью лекарственного вещества |
AU2006331357B2 (en) * | 2005-12-29 | 2012-05-17 | Immupharma France Sa | Compositions and methods for synthesizing novel heterocyclic therapeutics |
EP1973887B1 (en) * | 2005-12-29 | 2012-09-19 | Immupharma France SA | Aza heterocyclics for the treatment of malaria or aids |
JP2009522234A (ja) * | 2005-12-29 | 2009-06-11 | イミュファルマ・フランス・エスアー | ホスホリパーゼa2を阻害する組成物および方法 |
US7777030B2 (en) | 2005-12-29 | 2010-08-17 | Centre National de la Recherge Scientifique (CNRS) | Compositions and methods for the treatment and prevention of disease |
WO2007074170A2 (en) * | 2005-12-29 | 2007-07-05 | Immupharma France Sa | Compositions and methods for the treatment and prevention of disease |
US20100240641A1 (en) * | 2006-05-26 | 2010-09-23 | Julien Papillon | Aldosterone Synthase and/or 11B-hydroxylase Inhibitors |
EP2129381A1 (en) | 2007-01-24 | 2009-12-09 | Glaxo Group Limited | Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1 |
KR101044833B1 (ko) * | 2010-02-10 | 2011-06-28 | (주)혜성나노텍 | 무차광 온실 보온커텐 종형 개폐장치 |
US9045460B2 (en) | 2010-08-26 | 2015-06-02 | Kowa Co., Ltd. | Production method for isoquinoline derivatives and salts thereof |
BR112013033388A2 (pt) | 2011-06-24 | 2017-01-24 | Constr Res & Tech Gmbh | composição cimentícia e mistura |
CN108358893A (zh) * | 2018-02-10 | 2018-08-03 | 安徽唯诗杨信息科技有限公司 | 一种一锅法合成四氢化苯并-[1,4]-二氮杂环庚烷衍生物的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022765A (en) | 1975-01-06 | 1977-05-10 | E. R. Squibb & Sons, Inc. | Triazolo[4,3-d][1,4]benzodiazepine-6-ones |
IL111960A (en) | 1993-12-17 | 1999-12-22 | Merck & Co Inc | Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them |
SK283070B6 (sk) | 1993-12-29 | 2003-02-04 | Merck Sharp & Dohme Limited | Substituované morfolínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie |
TW385308B (en) | 1994-03-04 | 2000-03-21 | Merck & Co Inc | Prodrugs of morpholine tachykinin receptor antagonists |
US5719156A (en) | 1995-05-02 | 1998-02-17 | Schering Corporation | Piperazino derivatives as neurokinin antagonists |
US5972938A (en) | 1997-12-01 | 1999-10-26 | Merck & Co., Inc. | Method for treating or preventing psychoimmunological disorders |
-
2001
- 2001-05-14 US US09/854,885 patent/US6452001B2/en not_active Expired - Fee Related
- 2001-05-18 AU AU8177801A patent/AU8177801A/xx active Pending
- 2001-05-18 JP JP2001586272A patent/JP4060596B2/ja not_active Expired - Fee Related
- 2001-05-18 DE DE60126614T patent/DE60126614T2/de not_active Expired - Lifetime
- 2001-05-18 AT AT01960225T patent/ATE353881T1/de not_active IP Right Cessation
- 2001-05-18 WO PCT/EP2001/005723 patent/WO2001090083A1/en active IP Right Grant
- 2001-05-18 KR KR10-2002-7015837A patent/KR100526696B1/ko not_active IP Right Cessation
- 2001-05-18 PT PT01960225T patent/PT1296961E/pt unknown
- 2001-05-18 ES ES01960225T patent/ES2280392T3/es not_active Expired - Lifetime
- 2001-05-18 DK DK01960225T patent/DK1296961T3/da active
- 2001-05-18 CN CNB018099335A patent/CN1178923C/zh not_active Expired - Fee Related
- 2001-05-18 MX MXPA02011464A patent/MXPA02011464A/es active IP Right Grant
- 2001-05-18 CA CA002409842A patent/CA2409842C/en not_active Expired - Fee Related
- 2001-05-18 AU AU2001281778A patent/AU2001281778B2/en not_active Ceased
- 2001-05-18 BR BR0111062-4A patent/BR0111062A/pt not_active Application Discontinuation
- 2001-05-18 EP EP01960225A patent/EP1296961B1/en not_active Expired - Lifetime
- 2001-05-21 PE PE2001000458A patent/PE20011266A1/es not_active Application Discontinuation
- 2001-05-23 AR ARP010102436A patent/AR028607A1/es unknown
-
2002
- 2002-11-04 ZA ZA200208940A patent/ZA200208940B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001090083A1 (en) | 2001-11-29 |
AU2001281778B2 (en) | 2005-06-02 |
PT1296961E (pt) | 2007-05-31 |
BR0111062A (pt) | 2003-06-10 |
US6452001B2 (en) | 2002-09-17 |
CA2409842A1 (en) | 2001-11-29 |
CN1430611A (zh) | 2003-07-16 |
JP4060596B2 (ja) | 2008-03-12 |
DK1296961T3 (da) | 2007-06-04 |
EP1296961B1 (en) | 2007-02-14 |
ES2280392T3 (es) | 2007-09-16 |
ZA200208940B (en) | 2004-02-04 |
KR100526696B1 (ko) | 2005-11-08 |
KR20030003759A (ko) | 2003-01-10 |
DE60126614D1 (de) | 2007-03-29 |
AU8177801A (en) | 2001-12-03 |
ATE353881T1 (de) | 2007-03-15 |
EP1296961A1 (en) | 2003-04-02 |
MXPA02011464A (es) | 2003-04-25 |
DE60126614T2 (de) | 2007-11-22 |
AR028607A1 (es) | 2003-05-14 |
US20020010174A1 (en) | 2002-01-24 |
CN1178923C (zh) | 2004-12-08 |
JP2003534332A (ja) | 2003-11-18 |
CA2409842C (en) | 2008-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE59999A1 (es) | Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona-8-sustituidos | |
PE20011266A1 (es) | Derivados de 1,4-diazepan-2,5-diona | |
EA200600315A1 (ru) | Пиримидиновые соединения, их применение в качестве a-селективных антагонистов и способ их получения | |
PE20021041A1 (es) | DERIVADOS DE DIHIDRO-BENZO[b][1,4]DIAZEPIN-2-0NA COMO ANTAGONISTAS II mGLUR2 | |
PE20020753A1 (es) | Heteroaromaticos fusionados como activadores de la glucoquinasa | |
PE20170189A1 (es) | Nuevos derivados de pirazolo pirimidina y su uso como inhibidores de malt1 | |
PE20010681A1 (es) | Derivados de benzodiazepina como antagonistas del receptor de glutamato metabotropico | |
PE20020298A1 (es) | Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona como antagonistas de receptores de neuroquinina nk-1 | |
PE20021072A1 (es) | DERIVADOS DE DIHIDRO-BENZO(b) (1,4)-DIAZEPIN-2-ONA COMO ANTAGONISTAS I DE mGLUR2 | |
PE20060625A1 (es) | Derivados de benzazepina como antagonistas y/o agonistas del receptor h3 de histamina | |
PE20000337A1 (es) | Pirazolpirimidinas y pirazoltriazinas | |
PE20020103A1 (es) | Derivados de 1-sulfonil-pirrolidina | |
PE20030471A1 (es) | Compuesto de imidazopiridin como moduladores del receptor 5-ht4 | |
ES2135543T3 (es) | Piperidinas (4-aril-sustituidas) como antagonistas de los receptores de neuroquininas. | |
PE20041061A1 (es) | Imidazol-4-il-etinil-piridina | |
PE20030761A1 (es) | Derivados del 7-amino-benzotiazol | |
EA199800702A1 (ru) | Хиноксалиндионы | |
PE20060770A1 (es) | Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1 | |
PE75199A1 (es) | Derivado de quinolina util como antagonista de neuroquinina | |
HUP0304101A2 (hu) | Pirazolszármazékok, eljárás előállításukra, alkalmazásuk, a vegyületeket tartalmazó gyógyszerkészítmények és intermedierjeik | |
ATE7598T1 (de) | Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide. | |
NO20065863L (no) | 3-[4-(6-(4,5-dihydroisoksazol-3-yl]pyridin-3-yl)-3-fenyl]-5-(1 H,1,2,3-triazol-1-yl-metyl)-1,3-oksazolidin-2-oner som antibakterielle midler | |
PE20020603A1 (es) | Derivados de pirimidina como antagonista del receptor del neuropeptido y (npy) | |
PE20010153A1 (es) | Derivados de 4-fenil-pirimidina como antagonistas del receptor de neuroquinina | |
PE20020436A1 (es) | Derivados de tetrahidropirano como antagonistas del receptor de neuroquinina 1 (nk-1) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |